MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Settings
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Ann Arbor, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 24 people enrolled
- Started
- 3 May 2021
- Ended
- 14 May 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Academic Detailing (AD)
- LEAP
- Record updated
- 15 October 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Note- the investigators are recruiting clinics - not individual patients
- Prior to implementation, the investigators will work with sites to ensure they have met the preconditions necessary to begin sustained optimization of the EBP:; a team leader or champion; an identified department with service leadership buy-in and control over the processes/practices impacted by the implementation; readily accessible data to measure process and impact of the implementation and use of the EBP; availability of required resources
Who cannot take part
- N/A
Where in United States
- VA Ann Arbor Healthcare System, Ann Arbor, MIAnn Arbor, United States
About the trial
What the trial wants to find out
Scientific advances are constantly leading to better treatments. However, it is quite challenging for healthcare systems, including VA, to ask very busy providers to change the way they practice. The MIDAS QUERI program will help providers improve the way they treat VA patients for three common conditions, using specific strategies to ensure the reliable delivery of these treatments. The first project will focus on reducing potentially inappropriate medication (PIM) use using the VIONE practice, developed in VA. The second project will focus on better use of drugs called direct oral anticoagulants (DOACs) for patients with a history of severe blood clots or an abnormal heart rhythm. The third project will focus on increasing the use of cognitive behavioral therapy for insomnia as the first-line treatment for insomnia instead of sleep medications. The investigators will test two implementation approaches to improve medication use within these topics.
The 2 groups in the trial
- Academic Detailing (AD) OnlyExisting treatment, for comparison
One-on-one educational outreach to employees and providers.
Treatment: Academic Detailing (AD)
- AD + LEAP CombinedTreatment being tested
This arm combines use of AD plus the Learn. Engage. Act. Process (LEAP) program. LEAP is a 6-month quality improvement coaching program plus a 6-month monthly follow-up.
Treatment: Academic Detailing (AD) and LEAP
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Maintaining Implementation Through Dynamic Adaptations (MIDAS) (QUE 20-025)
- Publications
- Record updated
- 15 October 2025